The Vistria Group, Nautic Partners and General Atlantic Acquire PANTHERx Rare
July 26, 2022
An investor consortium led by The Vistria Group, with Nautic Partners and General Atlantic, completed the acquisition of PANTHERx Rare, a Pittsburgh-based specialty pharmacy focused on rare and orphan diseases, closing on July 14, 2022. Following the close, Vistria Senior Operating Partner Nick Loporcaro was appointed Chairman of PANTHERx's board; the deal expands the buyers' capabilities in pharma services and rare-disease specialty pharmacy.
- Buyers
- The Vistria Group, Nautic Partners, General Atlantic
- Targets
- PANTHERx Rare Pharmacy
- Industry
- Healthcare Services
- Location
- Pennsylvania, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
The Vistria Group and Excellere Partners Acquire SCA Pharmaceuticals
January 21, 2021
Pharmaceuticals
The Vistria Group and Excellere Partners purchased all outstanding equity interests of SCA Pharmaceuticals from Enhanced Healthcare Partners. SCA Pharma, an FDA-registered 503B outsourcing facility with sites in Windsor, Connecticut and Little Rock, Arkansas, will continue to be led by CEO Milton Boyer while the new owners plan to accelerate facility expansion, automation and growth.
-
The Vistria Group Acquires BioCare, Inc.
November 8, 2021
Healthcare Services
The Vistria Group has acquired BioCare, Inc., a Tempe-based specialty pharmaceutical distributor, specialty pharmacy and pharmaceutical logistics provider. The deal is Vistria’s first investment from its $2.68 billion Fund IV and aims to support BioCare’s growth — both organically and via acquisitions — to expand access to therapies for rare and orphan diseases.
-
General Atlantic Acquires Majority Stake in CareMetx; Vistria Reinvests
January 14, 2021
Healthcare Services
General Atlantic has entered a strategic growth partnership to become the majority owner of CareMetx, a Bethesda-based technology-enabled hub services company that supports patient access to specialty medications. Existing majority shareholder The Vistria Group is reinvesting and Marty Nesbitt (Vistria) will serve as CareMetx chairman; financial terms were not disclosed.
-
Norgine Acquires Theravia
August 14, 2025
Pharmaceuticals
Norgine has completed the acquisition of Theravia, an international pharmaceutical company focused on therapies for rare and debilitating conditions. Theravia is now a wholly owned subsidiary of Norgine as the buyer begins integration to expand its rare-disease portfolio and extend product reach across Europe and Australia/New Zealand.
-
AnewHealth Acquires HomeFree Pharmacy Services; Vistria Group Takes Minority Stake
July 10, 2024
Healthcare Services
AnewHealth has acquired HomeFree Pharmacy Services and will merge it with ExactCare to expand its suite of at-home pharmacy and medication management solutions. In connection with the transaction, The Vistria Group has made a minority investment in AnewHealth; Nautic Partners remains the controlling owner of AnewHealth.
-
Trilantic North America Makes Minority Investment in Rarebreed Veterinary Partners
September 28, 2020
Healthcare Services
Trilantic North America closed a substantial minority investment in Rarebreed Veterinary Partners, a Portland, Maine–based, technology-enabled veterinary services platform. The investment will fund Rarebreed's growth plan; co-founders Dan Espinal and Sean Miller retain meaningful equity and will continue to lead the business. Existing equity investors Caremi Investments, Northwood Ventures and Halle Capital Management also participated in the financing round.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.